retatrutide type 2 diabetes trial results 2024 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending retatrutide type 2 diabetes phase

Low blood sugar is rare in people without diabetes

Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats

By this point, surgical weight loss has largely concluded

Like GLP-1, GIP travels through your bloodstream and activates specific GIP receptors in various organs

It has chicken, which ups the protein content, helping to keep you satisfied even when you only eat a small portion

Animal studies and small human trials have shown similar trends, and this new study builds additional evidence with larger and more generalizable real-world populations